The biophotonics market size was USD 67.09 Billion in 2025 and is projected to reach USD 145.64 Billion by 2033, with a CAGR of 10.20%. Rising demand for non-invasive diagnostics and imaging technologies is driving market growth, fueled by ongoing research and development efforts. The U.S. biophotonics market is expected to reach USD 37.87 Billion by 2033.

Biophotonics enables early disease identification and focused treatment, supporting precision healthcare. In 2025, North America dominated the market with 37.30% share, while Asia Pacific is expected to grow the fastest with a projected CAGR of 10.85% from 2026-2033. Key industry players include Hamamatsu Photonics, Olympus Corporation, and Affymetrix (Thermo Fisher Scientific).

In 2025, lasers held the largest share of 40.21% in the biophotonics market, with a CAGR of 10.76%. Live cell imaging is expected to grow the fastest at 10.91%. Medical diagnostics account for 55.27% share, with a projected CAGR of 10.70%. In-vivo technology dominates the market with a 58.21% share, while in-vitro technology is the fastest-growing segment with a CAGR of 10.49%.

Recent developments include Hamamatsu Photonics’ involvement in Japan’s NEDO project for quantum computing and Olympus’ partnership with Revival Healthcare Capital to develop endoluminal robotic systems. SNS Insider provides in-depth market research and consulting services to help clients navigate changing market dynamics and make informed decisions.

Read more at GlobeNewswire: Biophotonics Market Size to Surpass USD 145.64 Billion by